Perioperative management of kidney transplantation in patients with myasthenia gravis: a case report with literature review
Authors:
Open Access
- 20 June 2025
- journal article
- case report
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 11 (1) , 1-5
Abstract
Background: Myasthenia gravis (MG) is an autoimmune disease with the disorder of the neuromuscular junction, characterized by muscle weakness and easy fatigue. The disease is associated with the development of a myasthenic crisis caused by invasiveness or other factors. MG treatment includes immunosuppressants and blood purification therapy, similar to the immunosuppressive management in kidney transplantation (KTx). We performed KTx in patients with MG. Case presentation: A female patient with chronic renal failure had already been diagnosed with MG, and she had been treated with tacrolimus (TAC) and methylprednisolone (MP). Immunoadsorption therapy was performed twice weekly along with hemodialysis therapy. At 57 years of age, the patient underwent ABO-compatible, donor-specific antibody-positive living donor KTx. TAC, mycophenolate mofetil, MP, basiliximab, and rituximab were administered as immunosuppressants. Plasmapheresis and intravenous immunoglobulins were administered prior to KTx. Conclusions: In addition to perioperative invasiveness, a postoperative urinary tract infection had occurred, raising concerns regarding the onset of a crisis. However, the impact of plasmapheresis and other immunosuppressive therapies may have had a positive influence on the perioperative management in this case.Keywords
All Related Versions
This publication has 11 references indexed in Scilit:
- Immunosuppression-related neurological disorders in kidney transplantationJournal Of Nephrology, 2021
- Long‐term safety and efficacy of eculizumab in generalized myasthenia gravisMuscle & Nerve, 2019
- Dose optimization of tacrolimus with therapeutic drug monitoring and CYP3A5 polymorphism in patients with myasthenia gravisEuropean Journal of Neurology, 2018
- Rituximab as treatment for anti-MuSK myasthenia gravisNeurology, 2017
- Miastenia gravis posterior a trasplante renalNefrología, 2016
- Myasthenia gravis: subgroup classification and therapeutic strategiesThe Lancet Neurology, 2015
- Myasthenia gravis: an update for the clinicianClinical and Experimental Immunology, 2014
- Epidemiologic evidence for a changing natural history of myasthenia gravisNeurology, 1996
- Myasthenia gravis associated with cyclosporin treatmentNephrology Dialysis Transplantation, 1992
- Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 PatientsAnnals of Neurology, 1984